Buy CJC-1295 – No DAC 10mg Online

CJC-1295 No DAC is a synthetic peptide analog of growth hormone-releasing hormone (GHRH) designed to stimulate natural growth hormone secretion patterns. Research suggests it may help support growth hormone and IGF-1 levels by mimicking the body’s endogenous GHRH signals to promote pulsatile GH release, though long-term safety data remains limited.

Log in or sign up to get notified when this product becomes available.

Log In / Sign Up

$55.00

General info
Brand

NOVERA COMPOUNDS

Strength

10mg

CAS

863288-34-0

Chemical Formula

C₁₅₂H₂₅₂N₄₄O₄₂

Molecular weight

3367.9 g/mol

Peptide Sequence

Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg

Synonyms

MOD-GRF(1-29), CJC-1295 without DAC, modgrf, tetrasubstituted grf, modified grf

Storage

Store 2–8 °C (≤–20 °C long-term). RT exposure during transport acceptable. Protect from light.

Shelf life

24 months from the manufacturing date.

CJC-1295 – No DAC (10mg) About This Product

The CJC No DAC peptide is a synthetic 29-amino-acid analog of growth hormone–releasing hormone (GHRH), also referred to as Modified GRF (1-29). Laboratories that buy or order CJC No DAC peptide materials reference this compound for controlled laboratory research examining the behavior of short-acting GHRH analogs and growth-hormone–axis signaling under experimental conditions.

Unlike DAC-modified variants, this peptide does not include a Drug Affinity Complex, resulting in a shorter duration of activity in research models. Several targeted amino-acid substitutions improve resistance to enzymatic degradation while maintaining structural compatibility with GHRH receptors. In laboratory settings, the peptide has been used as a research tool to evaluate endogenous growth hormone signaling patterns.

Product Specifications

  • Molecular weight: 3367.9 g/mol
  • Molecular formula: C₁₅₂H₂₅₂N₄₄O₄₂
  • CAS numbers: 863288-34-0, 446036-97-1
  • Form: Lyophilized powder

CJC-1295 – No DAC (10mg) Key Features and Benefits

  • Chemical identity: 29-amino-acid GHRH analog (Modified GRF 1-29)
  • Purity: Commonly produced at ≥95%, verified by HPLC
  • Non-DAC format: Evaluated without long-acting carrier complexes
  • Short activity window: Studied in experimental systems requiring transient peptide exposure
  • Research focus: Examined in laboratory models assessing growth-hormone–axis signaling behavior
  • Format: Supplied as a lyophilized powder suitable for controlled laboratory handling

For laboratory research use only.

CJC-1295 – No DAC (10mg) Mechanism & Research Applications

CJC-1295 without DAC has been examined in laboratory studies as a synthetic GHRH analog that interacts with pituitary cell models to evaluate endogenous growth-hormone release mechanisms. Rather than delivering exogenous hormones, the peptide is used in experimental systems to study upstream regulatory signaling under controlled conditions.

Research applications include:

  • Growth-hormone–axis signaling studies in cell and animal models
  • Temporal secretion pattern investigations examining pulse timing and recovery
  • Metabolic regulation research models assessing downstream signaling markers
  • Sleep-associated hormone research systems focused on experimental timing variables

All applications described reflect controlled laboratory research contexts and do not imply clinical or therapeutic use.

CJC-1295 – No DAC (10mg) Dosing & Observed Effects in Research

Research protocols using CJC-1295 without DAC vary by study design, species, and experimental objective. In laboratory settings, reported experimental dosing commonly ranges from microgram-level quantities administered once or multiple times daily, depending on the model used.

A 10 mg vial is typically reconstituted with bacteriostatic water to prepare a concentrated stock solution, which is then diluted to working concentrations appropriate for specific assays. Administration timing in research models is adjusted to evaluate short-term signaling behavior and recovery intervals.

Reported laboratory observations include transient changes in growth-hormone–related biomarkers, signal-transduction markers, and other assay-specific experimental readouts. These findings are derived exclusively from controlled research environments and do not establish safety, efficacy, or clinical relevance.

CJC-1295 – No DAC (10mg) Storage, Safety & References

  • Store lyophilized vials at ≤ –20 °C; –80 °C recommended for long-term storage
  • Keep vials sealed, dry, and protected from light
  • Allow vials to equilibrate to room temperature before opening
  • Reconstitute only with bacteriostatic water using sterile technique
  • Store reconstituted solutions at 2–8 °C and use within 2–3 weeks
  • Avoid repeated freeze–thaw cycles; aliquot when necessary

Handle materials in accordance with institutional laboratory biosafety protocols. Review the Certificate of Analysis (CoA) and Safety Data Sheet (SDS) prior to use.

References

https://academic.oup.com/jcem/article-abstract/91/3/799/2843281

https://www.fda.gov/media/183819/download

https://pubchem.ncbi.nlm.nih.gov/compound/CJC1295-Without-DAC

https://pubmed.ncbi.nlm.nih.gov/17018654

Compliance Notice

This product is intended for laboratory research use only and is not approved for human or veterinary use.